Draper Triangle

Locomation, Inc. is a technology company based in Pittsburgh, Pennsylvania, specializing in the development of autonomous driving solutions for the trucking industry. Established in 2016, Locomation focuses on enhancing trucking safety and efficiency through its Autonomous Relay Convoy (ARC) system, which combines artificial intelligence with driver augmentation. This innovative approach allows one truck to autonomously follow a lead truck operated by a human driver, facilitating safer and more cost-effective transportation. The company aims to reduce truck-involved accidents and improve operational efficiency for trucking companies by leveraging advanced AI-driven systems for both commercial and defense applications.

Ikos is delivering a flexible on-demand leasing service for investors and analyzing internal data to guide future client investments. It simplifies the rental experience for landlords and renters with their adaptive process that transparently connects people with homes they want and desire while helping landlords and renters make informed decisions. Ikos was founded in 2017 and is headquartered in Pittsburgh, Pennsylvania.

Babel Health, LLC is a developer of a cloud-based risk adjustment platform aimed at government-sponsored health programs. Founded in 2014 and based in Pittsburgh, Pennsylvania, the company offers a Software-as-a-Service solution that enables users to manage compliant submissions across various systems, including encounter data processing and risk adjustment payment systems. Babel Health's platform features a user-friendly Extract, Transform, and Load (ETL) tool specifically designed for processing healthcare data, allowing mid-size health plans to effectively navigate and integrate new technology in a cost-efficient manner. The company's primary product is a fully operational application for Encounter Data Processing System submissions, which helps organizations streamline complex processes and enhance data management capabilities.

Locomation, Inc. is a technology company based in Pittsburgh, Pennsylvania, specializing in the development of autonomous driving solutions for the trucking industry. Established in 2016, Locomation focuses on enhancing trucking safety and efficiency through its Autonomous Relay Convoy (ARC) system, which combines artificial intelligence with driver augmentation. This innovative approach allows one truck to autonomously follow a lead truck operated by a human driver, facilitating safer and more cost-effective transportation. The company aims to reduce truck-involved accidents and improve operational efficiency for trucking companies by leveraging advanced AI-driven systems for both commercial and defense applications.

Containership, Inc. is a technology company based in Pittsburgh, Pennsylvania, that specializes in cloud-based solutions for container management. Established in 2015, it offers a Platform-as-a-Service that enables users to automate, scale, and deploy applications across various cloud environments and data centers. The company's open-source Docker hosting platform facilitates application deployment, cluster scheduling, and service discovery. Additionally, Containership provides a hosted service that includes features such as automated provisioning, marketplace integrations, load balancing, and cluster snapshots. This comprehensive approach allows businesses to efficiently manage their containerized applications and easily transition between different cloud providers.

RE2 Robotics, based in Pittsburgh, PA, is a Carnegie Mellon University spin-off founded in 2001 by Jorgen Pedersen. The company specializes in developing intelligent mobile manipulation systems designed for various industries, including defense, aviation, construction, energy, and healthcare. RE2 Robotics creates manipulator arms that offer human-like performance and intuitive interfaces, allowing users to remotely perform tasks in challenging environments, whether on the ground, in the air, or underwater. With a significant focus on military applications, over 400 of its robotic arms have been deployed for explosive ordnance disposal missions, enhancing safety and efficiency while reducing operational costs. The company's innovative technologies aim to save lives and improve the quality of life through advanced robotics.

Rhiza, Inc. develops an online marketing analytics platform that transforms big data into actionable insights for marketers and sales professionals. Founded in 2008 and based in Pittsburgh, Pennsylvania, with an additional office in Seattle, the company provides tools that empower media publishers and advertisers to enhance their marketing strategies. Rhiza's software enables users to visualize, analyze, and share information from diverse data sets, thereby facilitating better understanding of audiences, content, and advertising effectiveness. The platform is utilized by leading media organizations, allowing them to optimize media buys, track campaign performance, and devise new marketing plans. As of 2017, Rhiza operates as a subsidiary of Nielsen Holdings plc.

BodyMedia pioneered the development of wearable body monitors that collect physiological data for use in improving health, wellness and fitness. Founded in 1999, the company today provides a variety of around-the-clock on-body monitors utilizing proprietary technology that has been clinically validated for accuracy. Data captured by BodyMedia devices is used by consumers as well as health and wellness professionals to guide behavioral changes to control weight and promote an active lifestyle – two factors that are routinely cited as keys to combat and manage serious medical conditions. BodyMedia has amassed one of the largest databases of information about the human body, and the technology has been used in more than 100 clinical research studies covering health issues such as obesity, COPD, diabetes, cystic fibrosis, cancer, bariatrics, sleep and intensive care. BodyMedia is privately held and based in Pittsburgh, PA. For more information, visit www.bodymedia.com.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

BitArmor Systems was a security software company located in Pittsburgh, Pennsylvania, specializing in information-centric data security solutions. The company developed an integrated encryption technology designed to safeguard data across various devices, including laptops, desktops, USB drives, and email attachments. Its offerings included cloud-based encryption solutions for mid-market businesses, focusing on file and disk encryption to protect sensitive information stored in multiple formats like CDs, DVDs, storage servers, and tapes. BitArmor's innovative approach to data security garnered attention, ultimately leading to its acquisition by Trustwave Holdings, Inc.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

Aethon Inc. develops autonomous mobile delivery robot systems that enhance logistics within hospitals by transporting medications, meals, and materials. The company's flagship product, TUG, is an automated robotic delivery system that efficiently manages both scheduled and on-demand deliveries across various hospital departments. TUG employs RFID technology for effective asset tracking and can also handle trash removal. Aethon offers additional software solutions such as MedEx, which maintains chain-of-custody control for medication deliveries, and MedSafe, which oversees order preparation and courier tracking. Other products include TraySafe for medication replenishment and TubeSafe to prevent missing doses. Aethon's Intralogistics platform automates the movement of materials within healthcare facilities, improving operational efficiency and patient satisfaction. Founded in 1997 and based in Pittsburgh, Pennsylvania, Aethon was formerly known as Probotics Inc. and rebranded in 2001.

BodyMedia pioneered the development of wearable body monitors that collect physiological data for use in improving health, wellness and fitness. Founded in 1999, the company today provides a variety of around-the-clock on-body monitors utilizing proprietary technology that has been clinically validated for accuracy. Data captured by BodyMedia devices is used by consumers as well as health and wellness professionals to guide behavioral changes to control weight and promote an active lifestyle – two factors that are routinely cited as keys to combat and manage serious medical conditions. BodyMedia has amassed one of the largest databases of information about the human body, and the technology has been used in more than 100 clinical research studies covering health issues such as obesity, COPD, diabetes, cystic fibrosis, cancer, bariatrics, sleep and intensive care. BodyMedia is privately held and based in Pittsburgh, PA. For more information, visit www.bodymedia.com.

Renal Solutions is a company based in Warrendale, Pennsylvania, that specializes in the development of dialysis products and services. Founded in 2000 and acquired by Fresenius Medical Care in 2007, the company focuses on creating integrated medical devices for sorbent hemodialysis treatment. These devices provide a clinical care model tailored for patients with chronic and acute kidney failure, allowing healthcare practitioners to offer flexible and convenient treatment options. Renal Solutions aims to enhance renal care through innovative sorbent-based dialysis technologies.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

BodyMedia pioneered the development of wearable body monitors that collect physiological data for use in improving health, wellness and fitness. Founded in 1999, the company today provides a variety of around-the-clock on-body monitors utilizing proprietary technology that has been clinically validated for accuracy. Data captured by BodyMedia devices is used by consumers as well as health and wellness professionals to guide behavioral changes to control weight and promote an active lifestyle – two factors that are routinely cited as keys to combat and manage serious medical conditions. BodyMedia has amassed one of the largest databases of information about the human body, and the technology has been used in more than 100 clinical research studies covering health issues such as obesity, COPD, diabetes, cystic fibrosis, cancer, bariatrics, sleep and intensive care. BodyMedia is privately held and based in Pittsburgh, PA. For more information, visit www.bodymedia.com.

Renal Solutions is a company based in Warrendale, Pennsylvania, that specializes in the development of dialysis products and services. Founded in 2000 and acquired by Fresenius Medical Care in 2007, the company focuses on creating integrated medical devices for sorbent hemodialysis treatment. These devices provide a clinical care model tailored for patients with chronic and acute kidney failure, allowing healthcare practitioners to offer flexible and convenient treatment options. Renal Solutions aims to enhance renal care through innovative sorbent-based dialysis technologies.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

Helomics Corporation is a personalized healthcare company focused on oncology, providing innovative tools to assist physicians and patients in making informed decisions throughout the cancer care continuum. It has developed a Precision Cellular Analytical Platform that analyzes cellular data over a 25-35 day period. Among its key products are ChemoFx, which aids in selecting effective treatments for gynecologic cancer patients; BioSpeciFx, offering biomarker tests for evaluating tumor responses at the molecular level; and GeneFx products, which use gene signatures to inform treatment options for colon and lung cancer patients. Additionally, Helomics provides tumor profiling services, including bioinformatics and patient-derived tumor models, which enhance clinical research and drug development. The company employs artificial intelligence through its D-CHIP platform to create personalized oncology roadmaps for patients. Founded in 1995 and headquartered in Pittsburgh, Pennsylvania, Helomics operates as a subsidiary of Predictive Oncology Inc.

BodyMedia pioneered the development of wearable body monitors that collect physiological data for use in improving health, wellness and fitness. Founded in 1999, the company today provides a variety of around-the-clock on-body monitors utilizing proprietary technology that has been clinically validated for accuracy. Data captured by BodyMedia devices is used by consumers as well as health and wellness professionals to guide behavioral changes to control weight and promote an active lifestyle – two factors that are routinely cited as keys to combat and manage serious medical conditions. BodyMedia has amassed one of the largest databases of information about the human body, and the technology has been used in more than 100 clinical research studies covering health issues such as obesity, COPD, diabetes, cystic fibrosis, cancer, bariatrics, sleep and intensive care. BodyMedia is privately held and based in Pittsburgh, PA. For more information, visit www.bodymedia.com.

OnlineChoice is a Pittsburgh-based company founded in August 1999 that leverages the power of group buying to help consumers save on various goods and services, including electricity, natural gas, and communication services. By utilizing an online platform, OnlineChoice enables suppliers to market their offerings to large groups of consumers, thereby reducing their marketing costs. This collective purchasing model allows customers to access better prices and deals, making it an effective solution for those seeking to lower their expenses on essential services.